Key result
Cardiovascular-kidney-metabolic syndrome begins in childhood, driven early by excess adiposity and insulin resistance.
Why the study?
Cardiovascular, kidney, and metabolic disorders are increasingly recognised as interconnected across the life course, but the applicability of the cardiovascular–kidney–metabolic framework to paediatric practice needed evaluation.
Answers are grounded in this paper and cite their sources.
This review proposes that the cardiovascular-kidney-metabolic (CKM) syndrome is a life-course continuum beginning in childhood, underscoring the need for early identification and intervention.
Background: Cardiovascular, kidney, and metabolic disorders are increasingly recognised as interconnected across the life course. In children and adolescents, obesity and insulin resistance may coexist with hypertension, dyslipidaemia, dysglycaemia, kidney abnormalities, and early cardiovascular injury. This review evaluates the applicability of the cardiovascular–kidney–metabolic (CKM) framework to paediatric practice. Methods: Structured narrative review synthesised PubMed/MEDLINE-indexed evidence spanning paediatric obesity, insulin resistance, type 2 diabetes mellitus, hypertension, dyslipidaemia, kidney dysfunction, and cardiovascular phenotypes. Systematic reviews, evidence-based guidelines, randomised trials, and longitudinal cohorts were prioritised. Results: The reviewed evidence indicates that excess adiposity can promote insulin resistance, inflammation, dyslipidaemia, hypertension, endothelial dysfunction, and renal hyperfiltration, thereby linking metabolic, cardiovascular, and renal pathways. Increased arterial stiffness, greater carotid intima-media thickness, and adverse ventricular remodelling have been identified in high-risk young people. Longitudinal findings show that childhood cardiometabolic risk factors are associated with later cardiovascular and metabolic outcomes, while youth-onset type 2 diabetes represents a particularly severe phenotype with early multiorgan complications. Newer anti-obesity and antihyperglycaemic therapies may modify several components of the CKM pathway, although long-term paediatric cardiovascular and renal outcome data remain limited. Conclusion: CKM syndrome is best viewed as a life-course continuum whose biological trajectory may begin in childhood. Developmentally adapted paediatric staging, validated longitudinal biomarkers, and long-term intervention studies remain important research priorities.
No takes yet. Share an insight, caveat, or question.
Soliman et al. (2026) conducted a review in Cardiovascular-Kidney-Metabolic Syndrome. Excess adiposity and insulin resistance was evaluated. The cardiovascular-kidney-metabolic (CKM) syndrome acts as a life-course continuum beginning in childhood, where excess adiposity and insulin resistance drive early multiorgan complications.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: